21 results on '"Swaak, AJG"'
Search Results
2. Regulation of ferritin: a specific role for interferon-alpha (IFN-alpha)? The acute phase response in patients treated with IFN-alpha-2b
3. Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies including Therapeutic Trials (ESCISIT)
4. Histone-containing immune complexes are to a large extent responsible for anti-dsDNA reactivity in the Farr assay of active SLE patients
5. Intrapleural administration of tumour necrosis factor-alpha (TNFalpha) in patients with mesothelioma: cytokine patterns and acute-phase protein response
6. Systemic toxicity and cytokine/acute phase protein levels in patients after isolated limb perfusion with tumor necrosis factor-alpha complicated by high leakage
7. Effects of tumour necrosis factor alpha and melphalan on the cytokine production of circulating T cells in patients with cancer
8. Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation
9. The Fc gamma RIIIA-158F allele is a risk factor for systemic lupus erythematosus
10. Klinisch denken en beslissen in de praktijk. Een patiënt met lupus erythematodes disseminatus en gedragveranderingen
11. Regulation of iron metabolism in the acute-phase response: interferon gamma and tumour necrosis factor alpha induce hypoferraemia, ferritin production and a decrease in circulating transferrin receptors in cancer patients
12. NO EVIDENCE FOR AN INDEPENDENT ROLE OF ANTI-HEPARAN SULFATE REACTIVITY APART FROM ANTI-DNA IN LUPUS NEPHRITIS
13. Essential cryoglobulinaemia (type 1) in three patients characterised by Raynaud's phenomenon, arthralgia-arthritis, and skin lesions
14. A NEW ELISA FOR THE DETECTION OF ANTI-HEPARAN SULFATE REACTIVITY, USING PHOTOBIOTINYLATED ANTIGEN
15. EFFECTS OF RECOMBINANT TUMOR-NECROSIS-FACTOR (RTNF-ALPHA) IN CANCER - OBSERVATIONS ON THE ACUTE-PHASE PROTEIN REACTION AND IMMUNOGLOBULIN-SYNTHESIS AFTER HIGH-DOSE RECOMBINANT TNF-ALPHA ADMINISTRATION IN ISOLATED LIMB PERFUSIONS IN CANCER-PATIENTS
16. Acute-phase response patterns in isolated hepatic perfusion with tumour necrosis factor alpha (TNF-alpha) and melphalan in patients with colorectal liver metastases
17. Absence of severe systemic toxicity after leakage controlled isolated limb perfusion (ILP) with high-dose TNF?? + melphalan
18. Common variable immunodeficiency in a patient with systemic lupus erythematosus
19. Reply
20. Anemia of chronic disease in patients with rheumatoid arthritis -- use of zinc protoporphyrin (ZPP) levels.
21. Prevalence and Significance of Haematological Abnormalities in Patients with Systemic Lupus Erythematosus
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.